Spyre Therapeutics, Inc. · NASDAQ:SYRE
Paradigm Biocapital Advisors LP reported a 5.10% stake in Spyre Therapeutics, Inc. (Schedule 13G)
Event Sep 24, 2026 · Filed Oct 1, 2026
Paradigm Biocapital Advisors LP reported a 5.10% stake in Spyre Therapeutics, Inc., 4,457,450 shares, as a passive investor on Sep 24, 2026. Filed Oct 1, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 4,457,450
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paradigm BioCapital Advisors LP | 5.10% | 4,457,450 |
| Paradigm BioCapital Advisors GP LLC | 5.10% | 4,457,450 |
| Senai Asefaw, M.D. | 5.10% | 4,457,450 |
| Paradigm BioCapital International Fund Ltd. | 4.50% | 3,928,646 |